Digital
June 25 - 26, 2020

2nd Annual MarketsandMarkets Cell-Gene therapy Bioprocessing Online Conference( Time Zone - EASTERN STANDARD TIME (EST)

30+
Speaker
10+
Networking Hours
150+
Attendees

Virtual engaging model to exact solutions for robust manufacturing and bioprocessing challenges

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. In our conference of 2017, we assessed the specific risks and benefits of the cell culture and cell therapy bio-manufacturing for the cure of these diseases.

There are still factors like manufacturing maze, investment, logistics and regulatory challenges that prevent the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 2nd Annual MarketsandMarkets Cell & Gene Therapy Bioprocessing Online Conference. Learn from the leading experts of the industry about strategies, technologies, and innovations in the area of bioprocessing of cell-gene therapies.

Due to growing concerns about COVID-19, the event is going fully virtual this year. We have created a virtual engaging model that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 25th & 26th June 2020. Please write to [email protected] for questions regarding speaking, attending and sponsoring. We will keep you posted with the event flow soon. Keep checking our website.

WHAT TO EXPECT

Key Highlights

  • Bioprocessing of 3D cell culture
  • CHO cell lines bioprocessing
  • Automation of cellular therapies
  • AAV vector production
  • Process development and monitoring of cell-gene therapies
  • Optimization of cell-gene therapies
  • Supply chain and reimbursement issues
  • Regulatory guidelines cell and gene-based medicines

Why Attend?

  • Learn the latest advancement and opportunities in the area of manufacturing of cell-gene therapies
  • Gain insights in the area of the automated and most effective manufacturing processes
  • Network with the key professionals addressing the strategies of supply chain and regulatory hurdles

Who Should attend?

From Therapeutics and Pharmaceuticals, Cell & Gene therapy-based companies:

Engineers/ Scientists/ Researchers/ Project leaders in:

  • Bioprocess development
  • Process development
  • GMP/Manufacturing
  • Cellular Therapy
  • Gene Therapy
  • Quality Control
  • Cell Engineering
  • Regulatory affairs

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Tiffany Rau
Tiffany Rau
Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-, Biotechnology, Biopharmaceuticals
Shon Green
Shon Green
Director, Clinical Translation, Altius Institute for Biomedical Sciences
Scott Burger
Scott Burger
Principal, Advanced Cell & Gene Therapy LLC
Geoffrey Hodge
Geoffrey Hodge
Chief Technical Officer , Unum Therapeutics
Speakers
Shailendra Singh (Shelly)
Shailendra Singh (Shelly)
Board Member, MarketsandMarkets
Tiffany Rau
Tiffany Rau
Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-, Biotechnology, Biopharmaceuticals
Scott Burger
Scott Burger
Principal, Advanced Cell & Gene Therapy LLC
Jan Joseph Melenhorst
Jan Joseph Melenhorst
Adjunct Associate Professor, Upenn
John Rossi,
John Rossi,
Vice President, Head, Translational Medicine, , Syncopation Lifesciences
Devyn Smith
Devyn Smith
Chief Executive Officer, Arbor Biotechnologies
Hemant Dhamne
Hemant Dhamne
Head of Vector and CAR-T Cell Processing, Immuneel Therapeutics Pvt Ltd
Don Healey
Don Healey
SVP Operations and Site Head, KBI Pharma
SPONSORS
Leading Partner
example-image

SCIEX

Sponsors & Exhibitors
example-image

GenScript

example-image

Eppendorf

example-image

OXGENE

example-image

Proteintech

Speaking Partner
example-image

Tosoh Bioscience

example-image

CPC

Primary Partner
example-image

SGS

PAST EVENT GALLERY